« Previous article
Robotic Solution for...

10th May 2021  Content supplied by: Lonza Pharma&Biotech - Bioscience Solutions

The Next Chapter . . . Lonza’s Endotoxin and Pyrogen Testing Solutions

The safety of injectable medicinal drugs is critically dependent on reliable quality control ensuring the absence of pyrogens, predominantly endotoxins, throughout drug development and routine manufacturing. For the last few decades, endotoxin testing has evolved to reach today’s optimized test systems that include robust reagents, traceable reference standards, data integrity compliant software, and qualified instrumentation.

However, traditional endotoxin tests still rely on a natural resource, the Limulus amebocyte lysate (LAL) prepared from the blue blood of the horseshoe crab. While conservation efforts have led to stable populations in North America, other populations are under pressure. Robust industry growth and global harmonization of pharmaceutical production sites have increased the interest and demand for sustainable pyrogen and endotoxin testing reagents and automated systems that provide reliable results throughout the drug development process.

Based on decades of experience in pyrogen testing, Lonza provides a portfolio of testing solutions to meet your current endotoxin and pyrogen testing needs, while providing qualified options to sustain your future growth:


The next chapter in endotoxin testing. . . Let's write it together.

Visit: bioscience.lonza.com/endotoxin-testing



Date Published: 10th May 2021

Source article link: View

View full company details

Lonza Pharma&Biotech - Bioscience Solutions


8830 Biggs Ford Road, Walkersville

United States

Tel: +[1] 800-521-0390

Email Supplier

View full company details

Related news from Lonza Pharma&Biotech - Bioscience Solutions